Comvita Limited — Director's Dealing 2018

Sep 17, 2018

==> picture [88 x 23] intentionally omitted <==

==> picture [179 x 81] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:

Comvita Limited 17-Sep-18 23-Aug-18 Sarah Jane Kennedy Comvita Limited n/a Company Director

Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Nature of the affected relevant interest(s):

Ordinary Shares Sarah Jane Kennedy - Power to exercise, right to vote and power to acquire or dispose of product (full personal ownership) Craigs Start Scheme A/C - Beneficial Holding Sarah Jane Kennedy - 4,700 Craigs Start Scheme A/C - 7,133 Sarah Jane Kennedy - 8,865 Craigs Start Scheme A/C - 7,133 Sarah Jane Kennedy Same as current registered holder 1

For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered: Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:

1 14-Sep-18 Sarah Jane Kennedy - purchase of 4,165 shares on market n/a $25,114.95 1

If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

n/a n/a n/a

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

==> picture [86 x 37] intentionally omitted <==

17-Sep-18